M, C., T, O., K, V., M, O., & C, S. (2024). Targeted radiopharmaceuticals: An underexplored strategy for ovarian cancer. Theranostics, 14(16), 6281. https://doi.org/10.7150/thno.99782
Chicago Style (17th ed.) CitationM, Crabbé, Opsomer T, Vermeulen K, Ooms M, and Segers C. "Targeted Radiopharmaceuticals: An Underexplored Strategy for Ovarian Cancer." Theranostics 14, no. 16 (2024): 6281. https://doi.org/10.7150/thno.99782.
MLA (9th ed.) CitationM, Crabbé, et al. "Targeted Radiopharmaceuticals: An Underexplored Strategy for Ovarian Cancer." Theranostics, vol. 14, no. 16, 2024, p. 6281, https://doi.org/10.7150/thno.99782.
Warning: These citations may not always be 100% accurate.